13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04634994 (ClinicalTrials.gov) | August 2021 | 9/11/2020 | Novel Assessment of Synaptic Density in Progressive MS | Novel Assessment of Synaptic Density in Progressive MS | Primary Progressive Multiple Sclerosis;Secondary Progressive Multiple Sclerosis;Relapsing Multiple Sclerosis;Multiple Sclerosis | Drug: [F-18]SDM-8 | Brigham and Women's Hospital | Massachusetts General Hospital | Recruiting | 18 Years | 60 Years | All | 30 | Early Phase 1 | United States |